Paces Ferry Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Paces Ferry Wealth Advisors's BMY Position: Q1 2026 in Review
Paces Ferry Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q1 2026, buying an estimated $8.8K and bringing the position to 4,423 shares worth $268K. The position accounts for 0.11% of the portfolio, ranked #111.
Paces Ferry Wealth Advisors first reported a position in BMY in Q3 2020 and has held it in 6 quarters since. The position peaked at $293K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Paces Ferry Wealth Advisors held 4,423 shares of Bristol-Myers Squibb worth $268K as of Q1 2026.
- Paces Ferry Wealth Advisors bought 151 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.8K.
- Bristol-Myers Squibb made up 0.11% of Paces Ferry Wealth Advisors's portfolio in Q1 2026, its #111 holding.
- Paces Ferry Wealth Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 6 quarters since.
- Paces Ferry Wealth Advisors's Bristol-Myers Squibb position peaked at $293K in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Paces Ferry Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.